Najit Technologies, Inc.

This study tested an inactivated chikungunya virus vaccine called HydroVax-005 CHIKV in 48 healthy adults aged 18 to 49. Participants received two doses of either a low or high dose of the vaccine or a placebo. The main goal was to check safety and how well the vaccine triggers a…

This Phase 1 trial tested an inactivated yellow fever vaccine called HydroVax-002 YFV in 26 healthy adults. Participants received two doses of either the vaccine or a placebo. The main goal was to check safety and side effects, while also measuring immune response. The trial is c…